{"id":1230,"date":"2026-06-15T19:45:17","date_gmt":"2026-06-15T18:45:17","guid":{"rendered":"https:\/\/www.loc-online.co.uk\/hertfordshire-loc\/?p=1230"},"modified":"2026-06-15T19:45:17","modified_gmt":"2026-06-15T18:45:17","slug":"semaglutide-special-educational-settings-ses-vouchers-locsu-and-fodo-news","status":"publish","type":"post","link":"https:\/\/www.loc-online.co.uk\/hertfordshire-loc\/2026\/06\/15\/semaglutide-special-educational-settings-ses-vouchers-locsu-and-fodo-news\/","title":{"rendered":"Semaglutide, Special Educational Settings (SES) Vouchers, LOCSU and FODO News"},"content":{"rendered":"<p>We have 4 items for you today:<\/p>\n<ol>\n<li style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\"><u><strong>Semaglutide (Wegovy, Ozempic and Rybelsus): Risk of Non Arteritic Anterior Ischemic Optic Neuropathy<\/strong><\/u><br \/>\n\tPrimary Eyecare Services (PES) advise:&nbsp;<\/p>\n<p>\tDear Colleague,<br \/>\n\tA Medicines and Healthcare products Regulatory Agency (MHRA) Alert&nbsp;has&nbsp;been received about Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non arteritic Anterior Ischemic Optic Neuropathy (NAION).<\/p>\n<p>\tPlease review the details for this MHRA Alert using the following link: <a href=\"https:\/\/www.college-optometrists.org\/news\/2026\/march\/glp-1-weight-loss-drugs-and-vision\" target=\"_blank\" style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #007C89;font-weight: normal;text-decoration: underline;\">risk of Non arteritic Anterior Ischemic Optic Neuropathy (NAION)&nbsp;and&nbsp;the guidance from the College of Optometrists<\/a>&nbsp;and take any necessary and appropriate actions.&nbsp;<\/p>\n<p>\tKind regards,<\/p>\n<p>\tPrimary Eyecare Services<\/li>\n<p><\/p>\n<li style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\"><u><strong>Patients in Special Educational Settings (SES) \u2013 GOS3 and GOS4 claims<\/strong><\/u><br \/>\n\t<img loading=\"lazy\" decoding=\"async\" data-file-id=\"14224608\" height=\"163\" src=\"https:\/\/mcusercontent.com\/dc3eb0fe766fd9065ecba9c49\/images\/40941f2b-9d9c-5ce3-d382-e579cbac76f5.jpg\" style=\"border: 0px;width: 310px;height: 163px;margin: 0px;float: right;outline: none;text-decoration: none;-ms-interpolation-mode: bicubic;\" width=\"310\"><br \/>\n\tPCSE advise:<\/p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\" style=\"border-collapse: collapse;mso-table-lspace: 0pt;mso-table-rspace: 0pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\">\n<tbody>\n<tr>\n<td style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\">&#8220;Dear Colleague,<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\" style=\"border-collapse: collapse;mso-table-lspace: 0pt;mso-table-rspace: 0pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\">\n<tbody>\n<tr>\n<td style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\">\n<p style=\"margin: 10px 0;padding: 0;mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #202020;font-family: Helvetica;font-size: 16px;line-height: 150%;text-align: left;\">The Special Educational Settings (SES) scheme supports children and young people who attend special schools by providing access to NHS sight tests delivered through the SES NHS sight test service.<\/p>\n<p>\t\t\t\tWhile sight tests may be&nbsp;carried out&nbsp;within a Special Educational Setting, patients are not restricted to using a specific ophthalmic contractor when it comes to dispensing. A patient, or their parent or carer, may present a GOS3 or GOS4 voucher to any ophthalmic contractor, including a high street practice.<br \/>\n\t\t\t\tThis means ophthalmic contractors may occasionally see SES patients even if they do not provide the SES NHS sight test service themselves.&nbsp;<\/p>\n<p>\t\t\t\t<strong>Submitting GOS3 and GOS4 claims for SES patients&nbsp;<\/strong><\/p>\n<p>\t\t\t\tWhen&nbsp;submitting&nbsp;a GOS3 or GOS4 claim for a patient who attends a Special Educational Setting, it is important to ensure the correct patient eligibility is selected on the Patient Eligibility screen in PCSE Online.<\/p>\n<p>\t\t\t\tIf the patient is recorded as being within a Special Educational Setting, there is no need to complete the following fields on the Patient\u2019s Declaration screen:<\/p>\n<ul>\n<li style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\">\n<p style=\"margin: 10px 0;padding: 0;mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #202020;font-family: Helvetica;font-size: 16px;line-height: 150%;text-align: left;\">Signatory (patient, parent,&nbsp;carer,&nbsp;or guardian)&nbsp;<\/p>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\">\n<p style=\"margin: 10px 0;padding: 0;mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #202020;font-family: Helvetica;font-size: 16px;line-height: 150%;text-align: left;\">Name&nbsp;<\/p>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\">\n<p style=\"margin: 10px 0;padding: 0;mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #202020;font-family: Helvetica;font-size: 16px;line-height: 150%;text-align: left;\">Address&nbsp;<\/p>\n<\/li>\n<\/ul>\n<p style=\"margin: 10px 0;padding: 0;mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #202020;font-family: Helvetica;font-size: 16px;line-height: 150%;text-align: left;\">No signature is&nbsp;required&nbsp;for an SES patient.<\/p>\n<p>\t\t\t\tThis applies regardless of which ophthalmic contractor&nbsp;submits&nbsp;the claim, provided the SES eligibility has been selected correctly.&nbsp;<\/p>\n<p>\t\t\t\t<strong>Important information&nbsp;about PMS systems&nbsp;<\/strong><\/p>\n<p>\t\t\t\tPlease note that no changes have been made to PMS systems as part of these updates.&nbsp;Contractors using a PMS should be aware that:&nbsp;<br \/>\n\t\t\t\t&nbsp;<\/p>\n<ul>\n<li style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\">\n<p style=\"margin: 10px 0;padding: 0;mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #202020;font-family: Helvetica;font-size: 16px;line-height: 150%;text-align: left;\">SES GOS3 and GOS4 vouchers must still be redeemed via PCSE Online.&nbsp;<\/p>\n<\/li>\n<\/ul>\n<p style=\"margin: 10px 0;padding: 0;mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #202020;font-family: Helvetica;font-size: 16px;line-height: 150%;text-align: left;\"><strong>Support&nbsp;<\/strong><\/p>\n<p>\t\t\t\tDetailed, step by step guidance on completing claims is available in the user guides:&nbsp;<\/p>\n<ul>\n<li style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\">\n<p style=\"margin: 10px 0;padding: 0;mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #202020;font-family: Helvetica;font-size: 16px;line-height: 150%;text-align: left;\"><a href=\"https:\/\/pcsengland.co.uk\/collect\/click.aspx?u=YzVJWm5OemdNWTcydG9xeXhDYjdsb2liNm00SEdVS0JWQ3hsZDRPTVFwdTlvQ05YTmVPM1hHWWIrSmN2L1RDSm9YRVV3K0RidVYxS24xcnZBN3hHUkVycXdtbWRYdkRsa2VBa2RIYmVCMDZERUxIM2FIcEF2UjQvVHpXcStTMUo=&#038;rh=ff01052918a6dfc4ff8bd2a914468621f1f1b896\" target=\"_blank\" style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #007C89;font-weight: normal;text-decoration: underline;\">GOS3 user guide<\/a>&nbsp;<\/p>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\">\n<p style=\"margin: 10px 0;padding: 0;mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #202020;font-family: Helvetica;font-size: 16px;line-height: 150%;text-align: left;\"><a href=\"https:\/\/pcsengland.co.uk\/collect\/click.aspx?u=YzVJWm5OemdNWTcydG9xeXhDYjdsb2liNm00SEdVS0JWQ3hsZDRPTVFwdTlvQ05YTmVPM1hHWWIrSmN2L1RDSmc0cUJrVDA0L2tjMHdVQ0d2RjI5djJUd0JubHZuQ0QvbklVQjF4YWZGNE5WYTN1TWRpcE9TWFZJWWh4aE95WmE=&#038;rh=ff01052918a6dfc4ff8bd2a914468621f1f1b896\" target=\"_blank\" style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #007C89;font-weight: normal;text-decoration: underline;\">GOS4 user guide<\/a>&nbsp;<br \/>\n\t\t\t\t\t&nbsp;<\/p>\n<\/li>\n<\/ul>\n<p style=\"margin: 10px 0;padding: 0;mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #202020;font-family: Helvetica;font-size: 16px;line-height: 150%;text-align: left;\">These guides include screenshots and&nbsp;additional&nbsp;information to support&nbsp;accurate&nbsp;submission of claims in PCSE Online.&nbsp;<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\" style=\"border-collapse: collapse;mso-table-lspace: 0pt;mso-table-rspace: 0pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\">\n<tbody>\n<tr>\n<td style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\">Best wishes,<\/p>\n<p>\t\t\t\tThe PCSE Ophthalmic Payments Team.&#8221;<br \/>\n\t\t\t\t&nbsp;<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\tThis statement can also be found online&nbsp;<a href=\"https:\/\/pcsengland.co.uk\/rv\/ff01052918a6dfc4ff8bd2a914468621f1f1b896\" target=\"_blank\" style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #007C89;font-weight: normal;text-decoration: underline;\">HERE.<\/a><\/li>\n<p><\/p>\n<li style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\"><u><strong>LOCSU News<\/strong><\/u><br \/>\n\tIs <a href=\"https:\/\/mailchi.mp\/9d3a7b5d200b\/march-2026-locsu-news-21076178?e=2bdb272d8d\" target=\"_blank\" style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #007C89;font-weight: normal;text-decoration: underline;\">HERE<\/a>, including&nbsp;A Shared Vision: World Optometry Week 2026, Case Studies and&nbsp;Uniting for a Glaucoma-Free World \u2013 Glaucoma Awareness Week 2026<\/li>\n<p><\/p>\n<li style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;\"><u><strong>FODO News<\/strong><\/u><br \/>\n\tIs <a href=\"https:\/\/www.fodo.com\/news-and-views\/more\/29698\/page\/1\/fodo-member-update-10-april\/\" target=\"_blank\" style=\"mso-line-height-rule: exactly;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color: #007C89;font-weight: normal;text-decoration: underline;\">HERE<\/a>, here including&nbsp;College and LOCSU publish new glaucoma resources,&nbsp;New GLP-1 guidance note for primary eye care and&nbsp;NHS Neighbourhood Health Framework.<\/li>\n<p>\n\t&nbsp;\n<\/ol>\n<p>Kind regards<\/p>\n<p>Herts LOC<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We have 4 items for you today: Semaglutide (Wegovy, Ozempic and Rybelsus): Risk of Non Arteritic Anterior Ischemic Optic Neuropathy Primary Eyecare Services (PES) advise:&nbsp; Dear Colleague, A Medicines and Healthcare products Regulatory Agency (MHRA) Alert&nbsp;has&nbsp;been received about Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non arteritic Anterior Ischemic Optic Neuropathy (NAION). Please review the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.loc-online.co.uk\/hertfordshire-loc\/2026\/06\/15\/semaglutide-special-educational-settings-ses-vouchers-locsu-and-fodo-news\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Semaglutide, Special Educational Settings (SES) Vouchers, LOCSU and FODO News&#8221;<\/span><\/a><\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1230","post","type-post","status-publish","format-standard","hentry","category-uncategorised"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.loc-online.co.uk\/hertfordshire-loc\/wp-json\/wp\/v2\/posts\/1230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.loc-online.co.uk\/hertfordshire-loc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.loc-online.co.uk\/hertfordshire-loc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.loc-online.co.uk\/hertfordshire-loc\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/www.loc-online.co.uk\/hertfordshire-loc\/wp-json\/wp\/v2\/comments?post=1230"}],"version-history":[{"count":1,"href":"https:\/\/www.loc-online.co.uk\/hertfordshire-loc\/wp-json\/wp\/v2\/posts\/1230\/revisions"}],"predecessor-version":[{"id":1231,"href":"https:\/\/www.loc-online.co.uk\/hertfordshire-loc\/wp-json\/wp\/v2\/posts\/1230\/revisions\/1231"}],"wp:attachment":[{"href":"https:\/\/www.loc-online.co.uk\/hertfordshire-loc\/wp-json\/wp\/v2\/media?parent=1230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.loc-online.co.uk\/hertfordshire-loc\/wp-json\/wp\/v2\/categories?post=1230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.loc-online.co.uk\/hertfordshire-loc\/wp-json\/wp\/v2\/tags?post=1230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}